Significant mutations in the spike protein of Omicron enhance its ability to evade immune responses [22], which may be associated with severe clinical outcomes such as cerebral embolism, deep vein thrombosis, and respiratory failure [23]. The gene discussed is CHMP5; the disease is intracranial embolism.